“BLOOD-BASED BIOMARKERS FOR PREDICTING POST-STROKE PROGNOSIS: A SCOPING REVIEW OF PENTRAXIN-3, NEUROPENTRAXIN-1, AND NEUROPENTRAXIN-2”. Magna Neurologica, vol. 4, no. 2, July 2026, pp. 175-86, https://doi.org/10.20961/magnaneurologica.v4i2.3308.